Cerebrospinal fluid JC virus antibody index for diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy-Reference-Cited by-同舟云学术

Cerebrospinal fluid JC virus antibody index for diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy

Published:2014-05-08 Issue:6 Volume:76 Page:792-801
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Warnke Clemens¹,von Geldern Gloria²,Markwerth Philipp³,Dehmel Thomas¹,Hoepner Robert⁴,Gold Ralf⁴,Pawlita Michael⁵,Kümpfel Tania⁶,Mäurer Mathias⁷,Stangel Martin⁸,Wegner Florian⁸,Hohlfeld Reinhard⁶,Straeten Vera⁹,Limmroth Volker¹⁰,Weber Thomas¹¹,Hermsen Derik¹²,Kleinschnitz Christoph¹³,Hartung Hans-Peter¹,Wattjes Mike P.¹⁴,Svenningson Anders¹⁵,Major Eugene²,Olsson Tomas¹⁶,Kieseier Bernd C.¹,Adams Ortwin³

Affiliation:

1. Department of Neurology, Medical Faculty; Heinrich Heine University; Düsseldorf Germany

2. National Institute of Neurological Disorders and Stroke; NIH; Bethesda MD

3. Institute for Virology; Heinrich Heine University; Düsseldorf Germany

4. Department of Neurology; Ruhr University; Bochum Germany

5. Research Program Infection and Cancer; German Cancer Research Center; Heidelberg Germany

6. Institute of Clinical Neuroimmunology; Ludwig Maximilian University and Munich Cluster for Systems Neurology (SyNergy); Munich Germany

7. Department of Neurology; Caritas Hospital; Bad Mergentheim Germany

8. Department of Neurology; Hanover Medical School; Hanover Germany

9. Department of Neurology; Johannes Wesling Hospital Minden; Minden Germany

10. Department of Neurology; Merheim Hospital; Cologne Germany

11. Department of Neurology; Marienhospital Hamburg; Hamburg Germany

12. Institute for Clinical Chemistry and Laboratory Diagnostics; University Hospital Düsseldorf; Düsseldorf Germany

13. Department of Neurology; University of Würzburg; Würzburg Germany

14. MS Center Amsterdam and Department of Radiology; VU University Medical Center; Amsterdam the Netherlands

15. Department of Pharmacology and Clinical Neuroscience; Umea University Hospital; Umea Sweden

16. Department of Neurology, Center for Molecular Medicine; Karolinska Institutet; Stockholm Sweden

Funder

BMBF

ECTRIMS

University of Dï¿½sseldorf

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ana.24153/fullpdf

Reference40 articles.

1. Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases;Clifford;Lancet Neurol,2010

2. Natalizumab and progressive multifocal leukoencephalopathy: what are the causal factors and can it be avoided?;Warnke;Arch Neurol,2010

3. Risk of natalizumab-associated progressive multifocal leukoencephalopathy;Bloomgren;N Engl J Med,2012

4. Case definition for progressive multifocal leukoencephalopathy following treatment with monoclonal antibodies;Mentzer;J Neurol Neurosurg Psychiatry,2012

5. Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring;Kappos;Lancet Neurol,2011

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Escalation to Anti-CD20 Treatment for Multiple Sclerosis Following Natalizumab-Associated Progressive Multifocal Leukoencephalopathy;Neurology Clinical Practice;2024-10

2. Highly restrictive and directional penetration of the blood cerebral spinal fluid barrier by JCPyV;PLOS Pathogens;2024-07-22

3. Progressive Multifocal Leukoencephalopathy;Neurology;2023-10-17

4. Progressive multifokale Leukenzephalopathie: Diagnostik und Therapieoptionen;Neurologie up2date;2023-06

5. Nationwide Laboratory Surveillance of Progressive Multifocal Leukoencephalopathy in Japan: Fiscal Years 2011–2020;Viruses;2023-04-14